Moderna (MRNA) Inventory Average (2021 - 2025)
Moderna (MRNA) has disclosed Inventory Average for 5 consecutive years, with $242.5 million as the latest value for Q4 2025.
- Quarterly Inventory Average fell 8.32% to $242.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $242.5 million through Dec 2025, down 8.32% year-over-year, with the annual reading at $135.0 million for FY2025, 15.36% down from the prior year.
- Inventory Average for Q4 2025 was $242.5 million at Moderna, down from $286.0 million in the prior quarter.
- The five-year high for Inventory Average was $2.0 billion in Q3 2022, with the low at $122.5 million in Q1 2025.
- Average Inventory Average over 5 years is $729.6 million, with a median of $487.0 million recorded in 2021.
- The sharpest move saw Inventory Average skyrocketed 525.32% in 2022, then crashed 77.23% in 2023.
- Over 5 years, Inventory Average stood at $1.2 billion in 2021, then rose by 25.77% to $1.5 billion in 2022, then plummeted by 77.23% to $344.5 million in 2023, then decreased by 23.22% to $264.5 million in 2024, then fell by 8.32% to $242.5 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods came in at $242.5 million, $286.0 million, and $184.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.